WallStreetZenWallStreetZen

NASDAQ: ATHE
Alterity Therapeutics Ltd Stock

Open Broker Account
$0.44-0.04 (-8.33%)
Updated Sep 30, 2022
ATHE Price
$0.44
Fair Value Price
$1.22
Market Cap
$18.00M
52 Week Low
$0.40
52 Week High
$1.38
P/E
-1.96x
P/B
0.72x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$8.92M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.17
Operating Cash Flow
-$9M
Beta
0.47
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ATHE Overview

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ATHE scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ATHE ($0.44) is undervalued by 63.91% relative to our estimate of its Fair Value price of $1.22 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ATHE ($0.44) is significantly undervalued by 63.91% relative to our estimate of its Fair Value price of $1.22 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
ATHE is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ATHE due diligence checks available for Premium users.

Be the first to know about important ATHE news, forecast changes, insider trades & much more!

ATHE News

Valuation

ATHE fair value

Fair Value of ATHE stock based on Discounted Cash Flow (DCF)
Price
$0.44
Fair Value
$1.22
Undervalued by
63.91%
ATHE ($0.44) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ATHE ($0.44) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ATHE is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ATHE price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.96x
Industry
14.28x
Market
27.64x

ATHE price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.72x
Industry
4.39x
ATHE is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ATHE's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
ATHE's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$28.7M
Liabilities
$4.1M
Debt to equity
0.17
ATHE's short-term assets ($28.97M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ATHE's short-term assets ($28.97M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ATHE's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ATHE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
ATHE's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ATHE vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ATHE$18.00M-7.76%-1.96x0.72x
ABEO$18.09M+2.70%-0.16x0.90x
TPST$18.13M+1.16%-0.55x0.52x
INDP$17.84M0.00%-1.14x0.59x
CNTX$17.72M0.00%0.09x0.43x

Alterity Therapeutics Stock FAQ

What is Alterity Therapeutics's quote symbol?

NASDAQ: ATHE) Alterity Therapeutics trades on the NASDAQ under the ticker symbol ATHE. Alterity Therapeutics stock quotes can also be displayed as NASDAQ: ATHE.

If you're new to stock investing, here's how to buy Alterity Therapeutics stock.

What is the 52 week high and low for Alterity Therapeutics (NASDAQ: ATHE)?

(NASDAQ: ATHE) Alterity Therapeutics's 52-week high was $1.38, and its 52-week low was $0.40. It is currently -68.12% from its 52-week high and 9.73% from its 52-week low.

How much is Alterity Therapeutics stock worth today?

(NASDAQ: ATHE) Alterity Therapeutics currently has 2,406,874,578 outstanding shares. With Alterity Therapeutics stock trading at $0.44 per share, the total value of Alterity Therapeutics stock (market capitalization) is $18.00M.

Alterity Therapeutics stock was originally listed at a price of $29.94 in Sep 29, 2003. If you had invested in Alterity Therapeutics stock at $29.94, your return over the last 19 years would have been -98.53%, for an annualized return of -19.92% (not including any dividends or dividend reinvestments).

How much is Alterity Therapeutics's stock price per share?

(NASDAQ: ATHE) Alterity Therapeutics stock price per share is $0.44 today (as of Sep 30, 2022).

What is Alterity Therapeutics's Market Cap?

(NASDAQ: ATHE) Alterity Therapeutics's market cap is $18.00M, as of Oct 2, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Alterity Therapeutics's market cap is calculated by multiplying ATHE's current stock price of $0.44 by ATHE's total outstanding shares of 2,406,874,578.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.